Ikena Oncology Inc (IKNA)
1.71
-0.02
(-1.16%)
USD |
NASDAQ |
Nov 22, 16:00
1.69
-0.02
(-1.17%)
After-Hours: 20:00
Ikena Oncology Cash from Investing (Quarterly): 9.454M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 9.454M |
| June 30, 2024 | 3.918M |
| March 31, 2024 | -48.74M |
| December 31, 2023 | 20.38M |
| September 30, 2023 | 31.89M |
| June 30, 2023 | 22.68M |
| March 31, 2023 | -10.81M |
| December 31, 2022 | 10.50M |
| September 30, 2022 | 35.78M |
| June 30, 2022 | 20.49M |
| Date | Value |
|---|---|
| March 31, 2022 | -166.05M |
| December 31, 2021 | -0.55M |
| September 30, 2021 | -0.184M |
| June 30, 2021 | -0.187M |
| March 31, 2021 | -0.839M |
| December 31, 2020 | 3.038M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.001M |
| March 31, 2020 | -0.117M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-166.05M
Minimum
Mar 2022
35.78M
Maximum
Sep 2022
-3.650M
Average
0.001M
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| MediciNova Inc | -0.0009M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.713M |
| Theriva Biologics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.938M |
| Free Cash Flow | -61.56M |
| Free Cash Flow Per Share (Quarterly) | -0.1852 |
| Free Cash Flow Yield | -74.75% |